Stay updated on Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Sign up to get notified when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The page shows new study record date entries for 2026-04-02, 2026-03-31, and 2026-03. Older dates 2026-02-10, 2026-01-29, and 2026-01 have been removed.
    Difference
    0.2%
    Check dated 2026-04-04T06:13:18.000Z thumbnail image
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.0, replacing the previous Revision: v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-21T01:20:52.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.4.3 was added and Revision: v3.4.2 removed, indicating a minor metadata update to the page.
    Difference
    0.1%
    Check dated 2026-03-06T18:44:20.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Added a new 'Moffitt Cancer Center Clinical Trials website' link and the sponsor organization name 'H. Lee Moffitt Cancer Center and Research Institute.' Introduced a new 'Helpful Links Provided by' section to house related links.
    Difference
    0.2%
    Check dated 2026-02-27T18:56:47.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    Deleted the Study Protocol and Statistical Analysis Plan PDF along with several boilerplate/footer items from the study page.
    Difference
    20%
    Check dated 2026-02-20T16:55:00.000Z thumbnail image
  8. Check
    56 days ago
    Change Detected
    Summary
    The update appears to be a site-wide template revision (Revision: v3.4.2) with removal of certain footer sponsor links; these changes do not modify the trial details or data. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-13T13:25:06.000Z thumbnail image

Stay in the know with updates to Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Interleukin-2 & Pembrolizumab for Kidney Cancer Clinical Trial page.